Keegan Harper

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Visiogen, Inc. develops products for cataract and refractive patients. It offers synchrony dual-optic accommodating intraocular lens and pre-loaded injector, which provide distance, intermediate, and near vision to presbyopic cataract patients. The company was founded on March 19, 2001 and is headquartered in Abbott Park, IL.

InSight Health Corp. provides diagnostic imaging and therapeutic healthcare services. It provides services to patients, physicians, managed care entities, hospitals and other contractual customers. The company was founded in 1996 and is headquartered in St. Louis Park, MN.

Comphya SA operates as a medical device company specialized in the treatment of erectile dysfunction to patient non-responsive to oral therapy. The company was founded by Rodrigo Fraga-Silva in 2017 and is headquartered in Lausanne, Switzerland.

Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada.

Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA.

Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA.

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA.

Aryballe sarl engages in the provision of biochemical sensors, optics, and artificial intelligence for odor analysis. The firm serves the automotive, food and beverage, consumer appliances, and personal care and cosmetics industries. It offers device solutions and software and data platform solutions. The company was founded by Tristan Rousselle in 2014 and is headquartered in Grenoble, France.

Aurigen Medical Ltd. develops cardiac implant products.

Aryballe Technologies SA develops and manufactures bio-inspired sensors enabling applications in digital olfaction. The company was founded by Tristan Rousselle and Thierry Livache on March 3, 2014 and is headquartered in Grenoble, France.

Rhythm AI Ltd. provides atrial fibrillation software that helps guide doctors during ablation procedures. The company was founded by Simon Hubbert, Richard Schilling John, Malcolm Finlay, Shohreh Honarbakhsh and Ross Hunter on December 21, 2018 and is headquartered in London, the United Kingdom.

Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany.

Creavo Medical Technologies Ltd. manufactures medical imaging devices for chest pain. It focuses on the utilization of advanced quantum principles in the rapid detection of potentially life threatening medical conditions in acute medical settings. Its flagship product, Quantum Vitalscan, is a battery powered and portable medical device that can be used in a routine and acute hospital setting. The company is headquartered in Coventry, the United Kingdom.

The Association of British Healthtech Industries Ltd. promotes products and services in the healthcare industry. The non-profit company is based in London, UK. The British company was founded in 1979. The CEO is Peter Ellingworth.

Part of Boston Scientific Corp., Cardiac Pacemakers, Inc. is a company that specializes in implanting pacemakers in patients with an abnormally low heart rate. The company is based in St. Paul, MN. The pacemakers are implanted under the skin, in the chest area, and are connected to the heart by transvenous leads that conduct electrical impulses to pace the heart and restore a normal heart rhythm. Patients implanted with a pacemaker must be regularly monitored by their cardiologist to ensure that the pacing system is working correctly. The company was founded by Manny A. Villafana.

Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA.

Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993.

Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018.

TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA.

swiss smile Holding AG operates as a holding company with interests in operates a chain of dental clinics. It offers treatments in the areas of aesthetic dentistry, bleaching, implantology, orthodontic, oral surgery, endodontic, pediatric dentistry, periodontology, professional teeth cleaning, bad breath, prosthetic, tooth-colored filling, teeth grinding, general anesthetic, and emergency aspects. The firm also provides whitening toothpastes, herbal toothpastes, whitening toothbrushes, soft toothbrushes, waxed dental tapes, and interdental brushes. The company was founded by Haleh Abivardi Brönner and Golnar Abivardi Signer in 2006 and is headquartered in Zurich, Switzerland.

Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland.

Aleva Neurotherapeutics SA develops next-generation implants for deep brain stimulation therapy. Its micro fabricated devices enable target specific stimulation and optimization of current therapies. The company was founded by Claudio Pollo, Jean-Pierre Rosat, Philipe Renaud, Paul Pyzowski and André Mercanzini and in August 2008 and is headquartered in Lausanne, Switzerland.

9905553 Canada, Inc. operates as a digital market place that allows buyers and sellers to list, negotiate, and finalize grain deals. The company was founded by Brennan Turner and Alain Goubau and is headquartered in Ontario, Canada.

Pairwise Plants LLC operates as a agriculture company. The company was founded by Feng Zhang, David Liu and J. Keith Joung and is headquartered in Durham, NC.

Plant Response, Inc. is engaged in providing agricultural biological services. It offers cybelion, power coat, biohp, neptunion, biopath and PRB9 products. The company is headquartered in Durham, NC.

Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019.

Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada.

Joyn Bio LLC is a joint venture between Leaps by Bayer and Ginkgo Bioworks that engineers microbes to improve naturally occurring processes in agriculture. The company is based in Boston, MA, and has two sites for leading scientists with diverse backgrounds. The company's focus is on developing probiotics for plants to provide growers with next-generation solutions to their biggest challenges. The company's first area of focus is on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture's reliance on nitrogen fertilizer and its environmental impact.

Oerth Bio LLC is an agricultural biotech company that develops sustainable, environmentally-designed crop and farm solutions to reduce the environmental impact of agrochemical solutions and nourish a growing population with eco-friendly, healthy foods. The company is based in Durham, NC. The company was formed as a joint venture between Arvinas and Bayer, supported by over $55 million in committed funding and operational support from Bayer, and technology and intellectual property from Arvinas. Oerth Bio is reimagining crop protection through a comprehensive, therapeutic approach to crop health using Protac® technology, a targeted biotech solution known for its potential in addressing human disease. The CEO of the company is John W. Dombrosky.